Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

STOP AF First Post-Approval Study

NCT: NCT05227053 · RECRUITING

NCT IDNCT05227053
StatusRECRUITING
Start Date2022-04-28
Completion2028-04

Brief Summary

The STOP AF First PAS is a prospective, global, multi-center, observational trial.

Frequently Asked Questions

What is STOP AF First Post-Approval Study?

STOP AF First Post-Approval Study is a clinical trial registered under NCT05227053. Current status: RECRUITING.

What is the status of NCT05227053?

The current status of NCT05227053 (STOP AF First Post-Approval Study) is: RECRUITING.

When did STOP AF First Post-Approval Study start?

STOP AF First Post-Approval Study started on 2022-04-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑